Bath & Body Works

BBWI

Market cap $3.61B

Bath & Body Works' international sales jump in Q4 as store expansion accelerates, signaling rising global demand and a capital-light path to long-term growth.

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you currently own shares of Bath & Body Works, Inc. (NYSE: BBWI)? Did you purchase any of your shares prior to June 4, 2024?

Bath & Body Works offers compelling value, trading near industry lows with a trailing EV/EBITDA of 5.5x and a free cash flow yield of 22.3%. BBWI's debt/lease load is significant at $4 billion, but near-term maturities are manageable, while recent free cash flow has supported both debt reduction and share buybacks. Insider buying surged after the November price drop, signaling board confidence and helping establish a support level around $14.

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Do you currently own shares of Bath & Body Works, Inc. (NYSE: BBWI)? Did you purchase any of your shares prior to June 4, 2024?

Bath & Body Works (BBWI) reported earnings 30 days ago. What's next for the stock?

Private equity (PE) firms have deployed trillions of dollars buying public companies, taking them private, restructuring operations, and selling at a profit.

Do you currently own shares of Bath & Body Works, Inc. (NYSE: BBWI)? Did you purchase any of your shares prior to June 4, 2024?

NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you currently own shares of Bath & Body Works, Inc. (NYSE: BBWI)? Did you purchase any of your shares prior to June 4, 2024?

NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you currently own shares of Bath & Body Works, Inc. (NYSE: BBWI)? Did you purchase any of your shares prior to June 4, 2024?

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE: BBWI).   Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.